Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$43.97 -0.63 (-1.41%)
At close: Sep 29, 2026 · 4:00 PM EDT

Supernus Pharmaceuticals (SUPN) Payables (2011 - 2026)

Updated

Supernus Pharmaceuticals (SUPN) recorded Payables of $108.46 million in Q2 2026, up 39.5% from $77.74 million a year earlier and up 7.1% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Payables (2011 - 2026) Analysis & Trends

At the end of FY2025, Supernus Pharmaceuticals reported Payables of $107.8 million, up 41.2% from FY2024.

  • Annual Payables has a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
  • Across earlier years, Payables came in at $76.35 million in FY2024 (-4.0%), $79.57 million in FY2023 (-84.0%), $498.31 million in FY2022 (+323.4%) and $117.68 million in FY2021 (+49.1%).
  • Quarterly Payables has ranged from $72.29 million in Q3 2021 to $498.31 million in Q4 2022 over the past five years.
  • On a year-over-year basis, Payables has increased for four consecutive quarters, with growth averaging 16.4% over the last eight quarters.
  • Peak year-over-year performance for Payables in the last five years was growth of 545.8% in Q3 2021, against a decline of 84.0% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $101.24 million (Q1 2026), $107.8 million (Q4 2025) and $108.61 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 20.92 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.30 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 5.96 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -22.89 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 7.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 429.50 Mn
10 Supernus Pharmaceuticals 2.59 Bn 1.25 Bn 185.39 Mn 108.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 108.46 Mn
Mar 31, 2026 101.24 Mn
Dec 31, 2025 107.80 Mn
Sep 30, 2025 108.61 Mn
Jun 30, 2025 77.74 Mn
Mar 31, 2025 76.89 Mn
Dec 31, 2024 76.35 Mn
Sep 30, 2024 75.80 Mn
Jun 30, 2024 82.61 Mn
Mar 31, 2024 86.40 Mn
Dec 31, 2023 79.57 Mn
Sep 30, 2023 78.47 Mn
Jun 30, 2023 83.04 Mn
Mar 31, 2023 497.85 Mn
Dec 31, 2022 498.31 Mn
Sep 30, 2022 110.30 Mn
Jun 30, 2022 133.00 Mn
Mar 31, 2022 89.43 Mn
Dec 31, 2021 117.68 Mn
Sep 30, 2021 72.29 Mn
API Access

Supernus Pharmaceuticals Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=SUPN&period=max&api_key=YOUR_API_KEY